SYK - Witnessing An Insider Decision James Andrew Pierce Exercises Options Valued At $2.37M At Stryker | Benzinga
On January 16, it was revealed in an SEC filing that James Andrew Pierce, Group President at Stryker (NYSE:SYK) executed a significant exercise of company stock options.
What Happened: A notable Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission revealed that Pierce, Group President at Stryker, exercised stock options for 10,230 shares of SYK, resulting in a transaction value of $2,372,030.
The Wednesday morning market activity shows Stryker shares down by 0.41%, trading at $313.01. This implies a total value of $2,372,030 for Pierce's 10,230 shares.
All You Need to Know About Stryker
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
Stryker: Delving into Financials
Positive Revenue Trend: Examining Stryker's financials over 3 months reveals a positive narrative. The company achieved a noteworthy ...